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The chemical synthesis and metabolic characteristics ductase (EC 1.1J.34) is the rate-limiting enzyme governing
of the lanosterol analogue, 15a-fluorolanost-7-en-3~- cholesterolbiosynthesis and thesynthesis of other isoprenoids
01, are described. The l5a-~uorosterol
is shown to be in mammalian cells (I).It has been suggestedthat regulation
a competitive inhibitor of the lanosterol l4a-methyl of this important enzyme in cellular metabolism i s under the
demethylase (Kt = 315 PM), as well as substrate for the control of a multivalent feedback process which involves
both
demethylase enzyme. Metabolic studies show that the
end
product
sterol,
as
well
as
other
non-steroidal
mevalonate15a-fluorosterol is converted to the corresponding
l6a-fluoro-3~-hydroxylanost-7-en-3~-a~dehyde
by derived products ( 2 ) . Results to date demonstrate that sterolhepatic microsomal lanosterol 14a-methyl demethyl- dependent regulation of reductase activity i s due primarily to
m e but that further
metabolic conversion to cholesterol a transcriptional control process which affects the level of
biosynthetic intermediatesis blocked by virtueof the reductase mRNA (3,4), although less dramatic post-transcrip16a-fluorosubstitution. When culturedcells are tional control by sterols has been observed (5). Conversely,
treated with the fluorinated lanosterol
analogue, a de- the non-steroidal regulation of reductase has been shown to
crease in3-hydroxy-3-methylglutaryl
(HMG)-CoAre- involve post-transcriptional mechanisms which entailenductase activity and immunoreactive protein was
observed. However, when the lanosterol 14a-methyl de- hanced enzyme degradation and decreased translational effm e t h y l a ~ - d e ~ c i e mutant
nt
cell line, ARM,is treated eiency of reductase message (6, 7). Thus,the differences
with the fluorosterol,no effect upon HMG-CoA reduc- between the two control processes are highlighted in terms of
tase is observed. Thus, metabolic conversion of the mechanism as well as affector molecule.
sterol to its 32-carboxaldehyde analogue
by the lanosRecently there has beenrenewed interest as to whether
terol 14a-methyl demethylase is required
for HMG- cholesterol or some oxysterol precursor or product of cholesCoA reductase suppressor activity. Measurement of terol metabolism is responsible for the observed steroidal
HMG-CoA reductase mRNA levels in 15a-fluorosteroltreated Chinese hamster ovary(CHO) cells reveals that regulation of HMG-CoA reductase activity, Generation of
mRNA levels are not decreased by the sterolas would regulatory oxysterols by means of a side pathway through
be expected for a sterol regulatorof HMG-CoA reduc- epoxycholesterol has been proposed as analternative to chotase activity. The decrease in ~MG-GOA
reductase pro- lesterol as the natural regulator of reductase activity (8-11).
tein is due to inhibition of enzyme synthesis, suggestingSimilarly, oxysterol intermediates generated along the normal
that the lba-fluorosterolreduces the translationalef- pathway of cholesterol biosynthesis have been shownto modficiency of the reductase mRNA. Measurements of the ulate the reductase in a manner consistent with their involvehalf-life of HMG-CoA reductase show that, in contrast ment in the regulatory process (12, 13). In the lattercase, it
to other oxysterols, the ~ ~ ~ - f l u o r o l a n o s t edoes
n o l not
increase the rate of degradation of the enzyme. Col- has been demonstrated that 3~-hydroxylanost-S-en-32-a1
lectively, these data support the premise that oxy- which arises during the course of lanosterol 14a-methyl delanosterols regulate HMG-CoA reductase expression methylation can serveto regulate HMG-CoA reductase activthrough a post-transcriptional process which may be ity when carbon flux through the sterol pathway is abnormally
distinct from other previously described sterol regu- high (13). Mechanistic studies have also demonstrated that
latory mechanisms.
accumulation of 3~-hydroxy~anost-S-en-32-a1
is favored over
demethylated end product under conditions when lanosterol
3 - H y ~ x y ~ 3 - m e t h y ~ g l u ~ ~ ~ -Ac o( eHn~~~m-eC o reA ~ ' substrate concentrations are saturating (14-16),thus supporting the cellular obse~ationson metabolic formation with
* This work was supported by a West Virginia University Senate kinetic data. Similarly, it has been suggestedthat thelevel of
Grant for Research (to I). A. L.). The costs of publication of this this same or comparable intermediate may decrease under
article were defrayed in part by the payment of page charges. This conditions when substrate pools favor carbon flow to cholesarticle must therefore be hereby marked ~ ' ~ ~ e r t ~ e m
in eaccordn~'7
terol (17). Collective~y,these observations support the notion
ance with 18 U.S.C. Section 1734 solely to indicate this fact.
in situ may
$ T o whom correspondence should be addressed. Tel.: 302-695- that accumulation o~3~-hydroxylanost-S-en-32-al
7110; Fax: 302-695-7873.
be the result of a designed integrated regulatory process which
The abbreviations used are: HMG-CoA, 3-hydroxy-3-methylglu- serves to control endogenous cholesterol biosynthesis under
taryl coenzyme A; CHO, Chinese hamster ovary; HPLC, high per- normal physiological fluxes of carbon flow-through the sterol
formance liquid chromatography; GC/MS, gas chromatography/mass
spectroscopy; TMS, t r i ~ e t h y l s i l yCHO,
~
Chinese hamster ovary; pathway.
The importance of the 3~-hydroxylanost-S-en-32-~
in the
NOE, nuclear Overhauser effect; DLSP, delipidated fetal bovine
serum.
regulation of HMG-CoA reductase and a detailed understand-
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ing of its mechanism have been hampered, however, by inadequate experimental systems whichallow one to monitor
specific effects of the endogenously generated sterol metabolite. One approach which we have taken to solve this dilemma
has been through the generation of cholesterol biosynthetic
mutants which allowdissection of the process genetically(18).
A second and equally important approach is to use synthetic
substrates. Thelatter approach has suffered in the past,
however, from the inherent problem that synthetic metabolites areultimately converted to cholesterol as a consequence
of normal metabolism. To circumvent this problem, we have
designed and synthesized a lanosterol analogue which can
only undergolimited metabolismby the lanosterol 14a-methyl
demethylase of the cholesterol biosynthetic pathway, The
compound described, l5a-fluorolanost-7-en-3~-ol,by virtue
of its 15a-fluor0 substitution, is incapable of undergoing a
complete demethylation cycle and subsequent conversion to
cholesterol (19,201 (Scheme I). This inability to be converted
to cholesterol makes the 15a-fluorolanosterol an ideal agent
to study the regulatory properties and mechanism of oxylanosterol formation and control of HMG-CoA reductase activity
in cultured cells.
In this report, we describe the metabolic characteristics of
the 15a-fluorolanostenoland conditions where the fluorinated
sterol is metabolized to its aldehyde analogue. Additionally,
we demonstrate that the 15a-fluorosterol is an active suppressor of HMG-CoA reductase activity in wild-type, but not
~anosteroll ~ ~ - m e t h y l d e m e t deficient,
h y l ~ e CHO cells.Most
i ~ t e r e s t ~ ~ gthe
l y ,r e g u l a t ~ oof~ HMG-CoA reductase by the
fluorinated lanostenol in cell culture experiments is shown to
be due to a post-transcriptional process analogous to nonsteroidal reductase regulators and not transcriptionalcontrol
as would be expected for a sterol. These results demonstrate
that cholesterol precursor sterols regulate HMG-CoA reductase and cholesterol biosynthesis by a mechanism distinct
tes.
from that of cholesterol and oxycholesterol ~ e ~ b o ~ i These
findings bring into question the identity of the putative HMGCoA reductase non-steroidal regulator which functions as a
post-transcriptional modulator of reductase expression.
EXPERIM~NTAL PROCEDURES

~e~~
~ a ~ o s t e ~4n-Methyl
ro~
D e ~ e ~ ~Assay-Lanosterol
~ ~ a s e
24nmethyl demethylase was assayed as described previously (16). Kinetic

analyses required the following assay m ~ ~ c a t i o Toluene
n.
stock
solutions containing1pCi of ~24,25-'W]24,25-dihy~o~anost"8-en-3fl~
01 substrate, 41.7-250 nmol, in addition to 0,50, or 100 nmol of 15afluorolanost-7-en-3fl-olfor each substrate concentration, were evaporated in the bottom of each assay tube under Nz to remove all
toluene. To each tube 5.0 mg of Triton WR1339 wasadded in acetone
to dissolve the sterols and then once again dried under Nz to form a
detergent-sterol film in the bottom of the tube. Dimethyl sulfoxide,
50 pl, was added to eachtube and vortex-mixed to suspend the
detergent-sterol matrix followedby additions of 25 pl of1.0 mM
AY9944 (in a 10% propylene glycol) and 10 pl of25 pM sodium
cyanide. Two mg of rat liver microsomes prepared from male SpraqueDawley rats that were fed a 3% cholestyramine diet (16) were added
to each tube in 390 &I of a I00 mM KxP04, pH 7.4,O.l mM EDTA,
0.1 EIM dithiothreitol, 20% glycerol buffer. The microsomes and
contents listed above were ~ u i l i b r a ~ d 37a "C
t for 5 min and the
assay initiated with 25pl of a 20 mM NADPH/isoc~tratedehydrogenase generator mix (16). All other aspects of stopping the assay,
saponification, extractions, and analysis by reverse-phase WPLC were
as described (16).
Metabolism of 125 nmol of lanost-7-en-3P-01 or 15a-fluorolanost7-en-30-01 were performed under the same conditions as described
above with the exception that 24,25-dihydroIanosterol was omitted.
The extracted nonsaponi~abiesterols were split in equal portions
and derivatized by the two schemes listed below and analyzed by GC/
MS.
Deriuatization of Sterols for GC/MS Analysis-The C32-oxysterol
products of lanost-7-ene-38-01 and Ea-fluorolanost-7-ene-30-01 are
unstableduring GC/MS analysis, since they decompose to their
respective A8(24) unsaturated sterolunder the high temperature
cond~tionsemployed during analysis (21). Therefore, separate procedures are described for characterizing the 3&32-dioi sterols versus
the 3~-hydroxy-32-aldehyde sterolsby GC/MS. The first procedure
requires that 3~-hydroxy-32-aldehyde sterols be reduced to a 32hydroxy group prior to derivation. The sterol sample was dissolved
in 500 p1 of methanol at room temperature, and 5.0 mg of NaBH,
was added and allowed to react for 3 h. Water, 2 ml, was then added
to quench the reaction, and the sterols were extracted with 10 ml of
petroleum ether. The petroleum ether extract was evaporated under
Ns gas and the reduced sterols subsequently derivatized to their
respective trimethylsilyl ethers. The reduced sterols were dissolved
in 200 p1 of dry pyridine and 200 btl of "Tri-Si1 TBT" reagent (Pierce
Chemical Co.), capped under N2 gas, and reacted overnight at 80 "C.
The TMS reaction mix was then dissolved in 10 mlof petroleum
ether andbackwashed with 2 ml of 10%solution of sodium bicarhonate. The organic phase was removed and evaporated to dryness under
Nz. The final sterol product was dissolved in 250 a1 of toluene, and
4.0-pl aliquots were analyzed by GC/MS as described beiow.
The alternatemethod for derivatizing 3@,32-&01sterols as well as
their respective substrates and demethylated products was accom-
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9
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SCHEME
I. 16a-FluoroIanost-7-en-

3@-01metabolism as catalyzedby the

lanosterol 14a-methyldemethylase.
Metabolism of the 15n-fluorolanostero1
proceeds through aldehyde formation.
Further metabolism of the lanostenol requires 15ol-proton loss which is prevented by the 15a-flUOrO substitution.
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plished by performing the "Tri-Si1 TBT" reaction as described here ting the appropriate band from the gel, solubilizing the slice with
without NaBH. reduction. As above, the final derivative was dissolved Protosol (Du Pont-New England Nuclear), and counting in a liquid
scintillation spectrophotometer. Background radioactivity was deterin 250 pl of toluene and 4.0 p1 was analyzed by GC/MS.
GC/MS Analysis of Sterols-Derivatized sterols were analyzed by mined with preimmune rabbit serum. The half-life of HMG-CoA
reductase was calculated from the slope of a semi-log plot of disinteGC/MS employing aHewlett-Packard
5890 gas chromatograph
equipped with 5970 mass selective detector (14). A capillary column grations/min in reductase versus time of chase.
Protein Determinations-Protein was determined by the Bio-Rad
of DB17-30W (J & W Scientific, Inc.) was used for sterol separations
with helium carrier gas andthe following temperature program: dye binding assay according to themanufacturer's directions employstarting temperature, 235 "C; ramp rate, 5'C/min; final temperature, ing bovine serum albumin as a standard.
265 "C. Total ion chromatograms were run in the ion range of 50-800
Materials
atomic mass units.
CellCulture-CHO
cells were cultured in McCoy's 5A medium
Preparation of ~~-Benzoyloxy-~5a-fl~orolanost-7-ene
(2f"The
(modified) supplemented with 1% Cab-0-Si1(Kodak) delipidated starting material (see Scheme 11) used to prepare the desired 15afetal bovine serum (DLSP) as described previously (13). Cells were fluorolanost"i'-en-3~-01was the previously reported 3P-benzoyloxyseeded at a density of 0.3 X lo6 in 60 X 15-mm tissue culture dishes lanost-7-en-15a-01 (26-29). Diethylamino sulfur trifluoride (5.75 ml,
(Costar) in 4 ml of the above medium 48 h prior to the start of each 46 mmol) was added to a solution of 3~-benzoyloxylanost-7-en-15aexperiment (13).
01 (1, 1.6 g, 2.92 mmol) in dry (distilled from phosphorus pentoxide)
AR45 cells, a CHO cellmutant deficient in lanosterol demethylase, dichloromethane (100ml) (30) under argon at -78". The reaction
were cultured in McCoy's 5A medium (modified) supplemented with was stirred a t -78 "C for 0.5 h, then diluted with dichloromethane
2.5% fetal bovine serum as described (18). Cells were washed twice (100 ml). Aqueous sodium bicarbonate was added until the aqueous
with Hanks' balanced salt solution (GIBCO) before replacing the phase was neutral, and the mixture was extracted with to1uene:ethyl
medium with 4 ml of McCoy's 5A medium (modified), 1% DLSP, 18 acetate, 1:1 (3 x 100 ml). The combined organic solutions were dried
h prior to the startof experiment.
over anhydrous magnesium sulfate, filtered, and solvents removed in
Determinatwn of HMG-CoA Reductase Activity, Immunoreactive vacuo to give 1.7 g of a complex mixture.
Protein, and Quuntitation of mRNALevels in Sterol-treated CHO
Purification by chromatography on silica gel (eluant5% ethyl
Cells-HMG-CoA reductase activity and immunoreactive protein acetateinhexane),
followed by HPLC on silica gel (eluant 25%
measurements were performed on cell homogenates exactly as de- toluene in hexane),yielded 294 mg (18% yield) of 3P-benzoyloxy-15ascribed previously in detail (13) or on permeabilized cell cultures as fluorolanost-7-ene (2).
reported by Leonard and Chen (22). Immunoblots were quantitated
Physical data (2): [.Iz5 = +45.9 t- 2.0" (c = 1.06, CHCI,); m.p. =
by scanning with an LKB UltroScan L densitometer.
226-227 "C (powder); RF = 0.50 (5% ethyl acetate in hexane); 0.15
HMG-CoA reductase mRNA levels were quantified by Northern
(25% toluene in hexane); NMR (300 MHz, CDCM: 8.06 (d, J = 7.4
blot analyses of poly(A+) RNA. For these determinations, cells were Hz, 2H, phenyl), 7.55 (m, IH, phenyl), 7.45 (m, 2H, phenyl), 5.51 (m,
seeded in 150-mm tissue culture dishes (Costar) at 0.9 X 106/dish in IH, 7-CH),5.05 (ddd, J = 56.6, 9.2,5.6 HZ, lH, 15-CHF),4.78
(dd, J
20 ml of McCoy's 5A (modified) medium containing 1% DLSP. Cells = 9.4, 5.6 HZ, IH, 3-CHO), 2.18-1.27 (m, 23H), 1.15 (s, 3H, 31-CH3),
were allowed to grow for up to 5 days a t 37 "C in 5% C02. On the day 1.10 (d, J = 3.6 HZ,3H, 32-CH3),0.95 ( s , 3H, CH3), 0.94 (9, 3H, CH3),
of treatment, the medium was replaced with fresh medium, and cells
(s, 3H, 18-CH3); IR
0.87 (unresolved d, 9H, 21,26,27-CH3),0.70
were treated with sterols suspended in 2.5% bovine serum albumin
(KBr, cm"): 2960 (m), 2930 (m, CH saturated), 1705 (s, C=O), 1460
in 5% ethanol such that the final ethanolconcentration did not
(m), 1450 (m), 1390 (m), 1380 (m), 1365 (m), 1280 (s, C-01,1120
exceed 0.5% (v/v). All treatments were done in triplicate. The treatment was continued for 16 h at which time cells were harvested by (m, C-F), 1035 (m), 1025 (m); MS (EI): 550 (20% M+), 413 (loo%,
first removing culture medium and washing with 3 X 10 ml of cold M-C8HsO2); high resolution mass spectroscopy for C3,Ha5O2F(M+):
(4 "C) 50 PM Tris-HC1, 155 pM NaCl, pH 7.4 (Tris/NaCl buffer). A calculated 550.4186, found 550.4163.
(3)"Lithium alumiPreparation of lScu-Muorolanost-7-en-3~-01
small portion (14 cm') of each culture which was removed by scraping
into 0.7 mf of Tris/NaCl buffer for activity measurements and im- num hydride (290 mg, 7.6 mmol) was added slowly to a solution of
(2294 mg, 0.534 mmol) in diemunoblots. Total RNA was isolated from the remainder of the cul- 3~-benzoyloxy-15a-fluorolanost-7-ene
tures by guanidineisothiocyanateextraction
and CsCl gradient thyl ether(40 ml) and tetrahydrofuran (10ml) a t 0 "C under nitrogen.
centrifugation, with further fractionationby oligo(dT)-cellulosechro- The reaction was stirred for 10 min, then quenched with the addition
matography (23). Poly(A+) RNA (2.5 pg) quantitated spectrophoto- of sodium sulfate decahydrate (1 9). The mixture was diluted with
metrically was electrophoresed in 0.66 M formaldehyde, 1%agarose diethyl ether (50 ml) followed by ethyl acetate (20 ml). The resultant
gels (23). Following transfer to nitrocellulose filters, hybridizations solution was filtered though a sintered glass funnel and the solvents
in vacuo. The resulting solid was crystallized from isoprowere performed with the following nick-translated [ C X - ~ ~ P J ~ A Tremoved
P(3).
labeled cDNA probes (23): the BamHIinsert of the HMG-CoA panol to give 230 mg (96% yield) of 15a-fluorolanost-7-en-3P-ol
reductase plasmid pRed227 (obtained from ATCC); the PstIinsert of The crystals had a m.p. = 159-160 "C, and the NMR showed cothe @-actin cDNA (24); and the PstI insert of the gluteraldehyde crystallization with isopropanol (2:1, 3:isopropanol). The crystals
phosphate dehydrogenase plasmid. pGAPDH plasmid (a kind gift were then dissolved in benzene and the solvent removed to give an
from K. Hastings and C. P. Emerson, Jr. to P. Benfield, Du Pont) amorphous solid.
( c = 0.5, CHC1,); m.p. =
Physical Data (3):[a]25= +24.64.0"
(25). The latter two probes were used as internal standards to quan172.5-173"C (powder); RF = 0.18(1:2:7,
ethyl acetate:toluene:
titate mRNA recovery. Autoradiography a t -70" for 3-24 h was used
to detect the location of radioactivity on filters, and mRNA quanti- hexane); NMR (300 MHz, CDC13): 5.50 (m, lH, 7-CH), 5.05 (ddd, J
tation was done by cutting individual bands from the filter and = 56.6, 9.2, 5.6 HZ, l H , ISP-CHF), 3.27 (dd, J = 10.6, 4.9 HZ, IH,3counting in a liquid scintillation counter. Similar results were ob- CHO), 2.18-1.27 (m, 23H), 1.10 (d, J = 3.6 Hz, 32-CH3), 1.01 (9, 'H,
CH,), 0.92-0.87 (m, 12H, methyls), 0.71 (s, 3H, 18-CH3); "F NMR
tained by densitometric scanning of autoradiograms.
(188.2 MHz, CDC13): -192.9 (ddq, J = 56.6, 27.5, 3.6 HZ 15-CHF);IR
HMG-CoA Reductase Synthesis and Degradation-Exponentially
growing cells were labeled in medium containing [35S]methionine(40 (CHC13,cm": 3620 (w, OH), 2960 (s), 2870 (m, CH sat), 1467 (m),
pCi/ml, 40 Ci/mmol). For synthesis measurements, cells were pulsed- 1448 (m), 1384 (m), 1367 (m), 1090 (w, CF), 1028 (m), 995 (m), 670
labeled with [36S]methioninefor 30 min at various times after treat- (m); MS (EI): 446 (65%, M+),431 (40%, M+ - CHJ, 413 (50%, M+
ment with sterols. For degradation measurements, untreated cells - CH3, H20), 306 (loo%, M+ - CgH160); high resolution mass
were labeled for 2 h with [35S]methionineand then cell monolayers spectroscopy for C30H,10F(M+):calculated 446,3924, found 446.3917;
were rinsed twice and incubated in medium containing 10 mM unla- EA for C30H610F:calculated, C 80.66%, H 11.51%, F 4.25%; found, C
beled L-methionine with or without oxylanosterol. Cells were har- 80.83%, H 11.29%, F 4.11%.
Synthesis of lanost-7-en-3P-01used in these studies was performed
vested in Tris/NaCl and frozen a t -80 "C. HMG-CoA reductase was
immunoprecipitated essentially as described by Tanaka et al. (5). as described by Woodward et al. (26).
Other Materials-A11 reagents used for lanosterol 14a-methyl deHMG-CoA reductase was immunoprecipitated with polyclonal antireductase igG. immunoprecipitates were solubilized a t 37 "C in SDS- methylase and HMG-CoA reductase activity determinations were as
(1120 Ci/mmol was
urea sample buffer and analyzed by electrophoresis on SDS, 10% described previously (13, 16). ~-['~S]Methionine
polyacrylamide slab gels [35S]methionine-labeledproteins were visu- from Du Pont-New England Nuclear. Guanidine isothiocyanate,
alized by fluorography using EN3HANCE (Du Pont-New England CsCl, and oligo(dT)-cellulose Type 2 and Type 3 were from GIBCO.
Nuclear). Radiolabeled HMG-CoA reductase was quantitated by cut- Agarose
was
from
Bio-Rad. Nitrocellulose was obtained from

-
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SCHEME 11. Synthetic route to 15a~uorolanost-7-en-3&01. Structures

1

shownrefer to those given in the
text
and identifiedby boided numerals.

J

Schie~cherand Schuell, and x-rayfilm was from Kodak. Anti-HMGCoA reductase IgG was a generous gift of Dr. Gene Ness, University
of Southern Florida.All other reagents were the best grade commercially available.

3 x 105

t

RESULTS

C ~ r ~ t e r ~ zofuJ5a-Fluorolanostt~n
7-en-3~-ol-The 15afluor0 stereochemica~assignment was critical for further studies with the l5a-ffuorolanosteno~ in our enzymic and cell
biolog~ca~
studies. This assignment was based upon NMR
studies. The ffuorine-pro~n coupling constant of 3.6Hz
I
which we observed betweenthe C32-methyl and the ffuorine
10
15
20
25
groups is consistent with the cis orientation as shown in
TIME ( m i n ~ t ~ s )
Scheme I (31). However, these data alone were insuffic~ent
FIG. 1. GC/MS c h r o m a t o g r ~of reaction products of 150rfor proper stereochemica~assignment, A d ~ t i o n aevidence
~
fluorolanost-7-en-3fl-olwith hepatic microsomes. The 1501was also provided by a series of nuclear Overhauser effect fluoroianostenol
(250 p ~ was
) incubatedwithhepaticmicrosomes
(NOE)studies. Previous NOE experiments conducted on 3p- (2.0 mg) for 1 h at 37 “C, at which time the assay was stopped by the
benzoyIoxytanost-7-en-l5icr-oi(27) gave an NOE between the addition of15%KOH in 95% methanol. Following saponification and
15s-hydrogenand the C18-methylgroup. Conversely,the 38- extraction, sterols were prepared for GC/MS analysis by reduction
benzoyloxylanost-7-en-15fi-ol
provided an observed NOE be- and TMS derivatizationasdetailedunder“Methods,”Chromato11.5
tween the 15a-hydrogen and the32 methyl. in thecase of the graphic peaks identifiedby retention time are: TMS-cholesterol,
min; choiesterol, 14.8 min; diTMS-l5~-fluorolanost-7-en-3~,32-diol,
only observed
ffuorinated steroid from the ~ e t h y ~ a m i sulfur
no
15.7 min; and T~S-15~-fluoro~anost-7-en-3~-01,
13.0 min.
triffuoride reaction, we observe an NOE between the 15~ y ~ o g and
e n the 18-methy~
group, By analogy to the above
cited experimen~,these NOE results, along withthe ffuorine- a retention time of 15.7 min rep re sen^ the derivatized 15aobtained through metabo~ismof
proton coupling cons tan^, allowed us to a s s i ~ e d
the fluori- ~uoro~anostenol-32-aldehyde
the
parent
substrate
seen
at
a
retention time of 19.0 min. No
nated steroid s t ~ c t u r eas the desired 3~-benzoyIoxy-l5ametabolite was seen when incubations were done anaerobiffuorolanost~7-ene(2).
cally or in the absence of NADPH (data not shown). As
Metabolic C ~ r ~ c t e r i ofs t ~I~a~F~~rolanost-7-en-38-nE
~
with Hepntic Microsomes-Once proper stereochemical as- mentioned above, the lability of oxy~anostenolsto the gas
signments had been made, our initial studies with the 15a- chromatographic conditions employed during analysis refluorosterol were designed to assess its metabolic behavior quired extensive derivatization prior t o G C m Sidentification
with hepatic microsomes.Previously, WE haveshown that (see ‘‘Methods”).Thus, the followingfragmentation ions were
lanostenols with a A7 double bond are poorly metabolizedby observed in themass spectrum of the reduced aldehydeTMS
the lanosterol demethylase despite having reasonableaffiiity derivative:571 (10%; M+ - F - CH3),516 (12%; M‘ HOTMS~,484 (95%;M+ - F - CHZOTMS), 413(20%; M* for the enzyme (32). This poor metabolic ~ h a r a c ~ r i s tcouic
.- C ~ Z O T M S 394(18%,
~,
M+ CgH~~OTMS,
393
pled with the inherent ~fficultyin detect~ng
oxylanosteno~s H O T ~ S
S
- HF) and379 (46%;M+
made formation and d e ~ c t i o nof the 15a-ffuoro-3P-hydroxy- (18%;M‘ - ~ O T -~CH~OTMS
S ~ . absence of a m o ~ e c u ~
ion
~ rof
lanost~7-en-32-aldehydea difficult task. Our efforts, there- - CH3 C g H ~ ~ O T MThe
fore, did not focus upon detailed kinetics of formation, but 606 is consistent with the reported behavior of the Ianosteno~
rather upon simple demonstration of formation with more 14ff-aIdehydein this GC/MS system (21). The loss of HF and
extensive characterization of the 15a-~uorolanos~roI
by in- F in the metabolite spectrum are also consistent with the
hibition kinetics toward the lanosterol 14a-methyl demeth- same type Iosses in the parent structure which shows: 518
(26%; M‘), 428 (30%; M”
HOTMS), 413 (88%; M+
ylase.
C&), 394 (10%;M” - F HOTMS CH3), 393
Shown in Fig. 1 is the GC/MS chromatogram of reaction H O T ”
HF
HOTMS
CH3). GC/MS analysis of
products generated during incubation of 15a-ffuoroianost-7- (10%; M”
en-3fi-01with hepatic microsomes. The peak correspondingto reaction mixtures which were not reduced prior to derivati-

-

-

-

-

-

-

-

-

-

zation revealed only modest amounts of d e t e c ~ b 14a-alco~e
hol (Table I). This finding indicates that the Ilia-alcohol is
present in the reaction mixture in much smaller amounts
compared with the l ~ ~ - a l d e h y dagain
e , consistent with previous metabolic studies employing ~ h y ~ o l a n o s t e r o(21).
l
Evidence for me~bolismof the 15a-fluoroIanosterol to the
32-formyloxy i n t e r m e ~ a t was
e not obtained in these studies.
We a t t r i b u ~this lack of a ~ ~ to~ generate
t y
the formylox~
intermediate to theinherent low rate of metabolism of the A7
lanosterol series (32) and the inability to generate the formyloxy intermediate when using lanosterol as substrate due
to thekinetic properties of the 14a-demethylase enzyme (33).
Further eva~uation of the l5a-~uorolanostenol as a substrate fox the lanosterol 14a-methy~ demethy~ase
was based
upon inh~b~tion
kinetics employing 24,25-~hy~olanosterol
as substrate with a cell-free preparation of the demethylase
enzyme. The double-reciprocalplot of demethylase activity in
-0.016
-0.008
0.000
0.008
the presence of several conce~trationsof the 15a-~uorolan1 /st1 JUM)
ost-7-en-3/3-01is shown in Fig. 2. The dataclearly demonstrate
that the sterol is a competitive inhibitor of the demethylase
FIG. 2. Kinetics of 16tu-fluorolaoost-7-en-3B-ol i n h i ~ ~ t ~ o ~
with respect to dihydrolanosterol showing a IC, = 315 pM. o f lanosterol 14a-methyl demethylase activity.
Lanosterol 14nThese data areconsistent with the observation that the15a- methyl demethylase was assayed using [2~,25-3~~J24,25-dihy~olanfluorosterol inhibits theconversion of C30sterols to C,, sterols osterol as substratein the absence (8)or presence of 100 pM (a)or
slopes of the reciprocal plots
in cultured CHO cells (50% inhibition at a concentration of 200 pM (A)l5~-ffuoro~anost-7-en-3~-ol.
of the kinetic data were determined and plotted against inhibit~r
5 PM in the culture medium, data not shown). Thus, the
concentration (inset) to determine the inhibition constant Ki= 315
notion that the 1 5 ~ - ~ u o r o ~ a n o s t eisnaosubstrate
~
for the p ~ Values
.
plotted are the mean of duplicate determ~nationswhich
lanosterol Ilia-methyl d~methylaseis confirmed by kinetic varied by less than 5%.
studies as well as by metabolic convers~on.
I
I
I
The Effect of ~ ~ a - F ~ ~ ~ ~ ~ ~ s t - 7upon
- e n ~- 3~/ 3G- 0~ 1 C o 140
A 1
I
~
e
~Actiuity
~
tin Chinese
~
e ~ u ~ t Ovary
e r Cetls-The next
series of experiments with the fluorinated sterol were conducted in CHO cells. Our interest was in the ability of the
compotrnd to modulate ~ ~ G - C reductase
oA
activity through
an oxys~rol-dependentmechanism. As shown in Fig. 3, the
l5a-fluorol~nosterolshows a concentration-dependent suppression of ~ M G - C o Areductase activity. This is a unique
and specific property for the 15a-fluoro-substituted fanosTABLE
I
GC/MS c ~ ~ ~ ~ e r i of~ ~u t~ ~ ~o n~ deriued
l i from
t ~ ~ s~ s t - ~ - e n ~ 3 B ~
with ~ p u ~ i c
~ ~ r o s o ~ ~ s
I n c u ~ t i o of
n sterols with hepatic microsomes was performed under
standard lanosterol demethy~aseconditions for 1h with the following
exceptions: 250 phrf sterol, 5.0 mg of Triton WR-1339, and 10%
dimethyl suIfox~de.Nonsaponi~ablesterols were extracted as described previousiy (16) and were split into two equal portions for
derivatization and analysis by the schemes outiined under"Methods."
This ~ i f f e ~ n t i derivatization
a1
procedure allows for quantitation of
both Ianosteroi 14~-aicohol and
14n-aldehyde me~bolities,as well as
demethylated diene sterol.

2o

01 and lfin-fluorokmost-7-en-3~-ol
~~~~~d

Substrate
."""

Lano~t-7-en"3~-0~'

15a-Fluoro-lanost-7-en38-olb

Total

Product
_

l

_

-

~

sterol
%

-

l

_

91.3
~nost-7-ene-3~,32"
0.8
diol
3 ~ - ~ y ~ x y ~ ~ o s t * 74.9
en-32-a1
~ , ~ - ~ i m e t h y ~ c h o l e s ~3.0~
7,14-dien-3~-01
97.1

l5~-Fluoro-lanost~~~
ene-3@,32-&01
3 ~ - H y ~ o x y -alphal5
ffuoro-lanost-7-en32-a1
Conversi~nrate = 0.09 nmol/min/mg.
Conversion rate = 0.03 nmol/min/mg.

0.6
2.3

_

_

t

0
0.0

i
0.5

1.o

1.5

2.0

pG /ML

FIG. 3. ~ u ~ ~ ~ of~~ s~ iG o
- Cno
reductase
A
activity in CHU
cells treated with 16a-fluorolanost-7-en-3~-0~.
Chinese hamster ovary cells were treated with increasing concentration of either
l5n-~uorolanost-7-en-3~-oI
or Ianost-7-en-3~-01as described under
"Methods." After 6-h exposure to thesterol, cells where processed for
HMG-CoA reductase activity determinations employing the ~ ~ t o n ~ n
ceil permeabilization assay (22). Results represent the average of
dupiicate determinations on replicate dishes. Clased circles, lanost-7en-3B-ok closed ~ r i a ~ g ~l5~-~uorolanost-7-en-3~~ol.
s,
Control
(100%) activity = 479 pmol/min/mg. Standard errors were less than
5%.

l

~

tenol, since lanost-7*en~~~-ol,
the n o n - f l u o r ~ n ~analogue,
~d
is without effect upon HMG-CoA reductase under identical
conditions (Fig. 3). The nature of the suppression is consistent
with an oxysterof-type ~ e c h a n ~ ssince
m
the decrease in
~ M G - C o Areductase activity is accompanied by a decrease in
the amountof immunoreactive reductase protein as shown in
Fig. 4. Con~rmation that 15~"fluorinated lanosteno~
required
metabolism by the lanosterol 14a-methyl demethylase to suppress HMG-CoA reductase activity in these cell experiments
was obtained through investigations employing the ~anostero~
14~-methy~ demethylase-de~cien~
m u t ~ AR45
t
(18). Treatment of AR45 cells with the ~uorinatedsterol does not
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tures have thus far been unsuccessful.
Evidence for a Post-transcriptional Mechanism of HMGCoA Reductase Regulation by l5a-Fl~rolan~st-7-en-3~-olTo furthercharacterize the suppression of HMG-CoA reductase caused by the 15a-fluorinated sterol, we measured the
amount of reductase mRNA in treated and nontreated CHO
cells. It was anticipated that the primary effect of the 15afluorosterol would be to change the level of reductase mRNA
in a manner consistentwith a transcriptional control process
97.4 +
analogously to other sterols (3, 4). The effect with the 15afluorolanostenol upon reductase mRNA, however, was opposite to thisexRectation. The results of a representativeexper1 2 3 4 5 6 7 8 9 1 0
iment are shown in Fig. 5 and Table 11. Chinese hamster
ovary cells treated with the compound actually showed an
increase in the amount of reductase mRNA compared with
controls. In four independentexperiments,
the increase
B
amounted to a 2-fold induction in reductase mRNA over a
15a-FL-A7-Lanost-3,9-ol
250H
16-h period. At the same time that the mRNA increase was
e
A7-Lanost-3B-ol
observed, the level of reductase proteinand activity decreased
to 16% of control levels (Table 111). This effect appears to be
unique for the fluorinated sterol since 25-hydroxycholesterol
decreased the amountof reductase mRNA, protein, and activity in agreement withpublished results (3,4).
97.4 +
T o further characterize the effects of the l5a-fluor0 analogue on HMG-CoA reductase gene expression, the rates of
reductase synthesis anddegradation were measured. SyntheI
2
3 4 5
6 7 8
9
sis of HMG-CoA reductase in CHO cells was measured by
monitoring the incorporation of [35S]methionineinto immunoprecipitable protein in the presence or absence of sterol.
The results of a representative experiment are shown in Fig.
C
6. Incubation of cells with the 15a-fluorolanostenol decreased
the rate of synthesis of reductase (Fig. 6B) in the absence of
any affect on total protein synthesis as assayed by the incorporation of [35S]methionineinto acid-perceptible protein (Fig.
6A). Table 111, which summarizes the results of four independent experiments, show that the 15-fluorolanostenol inhibits HMG-CoA reductase synthesis withoutcorresponding
a
decrease in mRNA levels. These observations suggest that in
contrast to the transcriptional regulation of HMG-CoA re”.
ductase reported for other oxysterols, regulation by the 150
.1
10
100
fluorolanostenol reduces the translationalefficiency of reducconcentratlon (PM)
tase mRNA.
FIG. 4. Immunoblot analysis of HMG-CoA reductase protein
The effects of 15a-fluorolanost-7-en-~-ol
on the half-life of
in sterol-treated cells. Chinese hamster ovary cells were treated HMG-CoA reductase were determined and results from a
with either lanost-7-en-3@-01or 15cu-fluorolanost-7-en-3@-olas described in the legend to Fig.3. A and B , cells were harvested by representative experiment are shown in Fig. 6C. Cells were

A

15a-FI-A7-Lano6t-3B-ol
A7-Lanoat-3B-ol
250H
0

scraping into sonication buffer, sonicated, and cell pellets isolated by
centrifugation. Cell pellets were suspended in SDS-polyacrylamide
gel electrophoresis buffer and 10 pg wasloaded per well for separation
and immunoblot analysis with anti-HMG-CoA reductase antibody.
A , wild-type CHO cells. B, lanosterol 14a-methyl demethylase-deficient mutant, AR45, cells. C, immunoblots from CHO cells treated
were quantitated by scanning with
with 15a-fluorolanost-7-en-3~-ol
a laser densitometer. The amount of immunoreactive proteinis
represented as the area under the absorbency curve. The average and
range of values from replicate dishes are shown. Parallel cultures
were harvested for determination of HMG-CoA reductase activity in
cell sonicates as described under “Methods.” Data for enzyme activity
represent the means and standard errors of four samples. 0, enzyme
activity; 0, immunoreactive protein.

produce a decrease in immunoreactive HMG-CoA reductase
protein (Fig. 4B) nordoes it inhibitreductase activity (control
= 471 f 30 pmol/min/mg; sterol = 539 & 25 pmol/min/mg; n
= 3). The lack of effect is not due to a nonresponsiveness of
the AR45 cells to oxysterols, since suppression of HMG-CoA
reductase is still observed when AR45 cells are treated with
25-hydroxycholesterol. Attemptsto isolate the metabolic
product of the 150-fluorolanosterol from wild-type CHO cul-

C 250H 15a-F

HMGR

-

GAPDH

-

@
I

I

FIG.5. Autoradiogram of Northern blot analysis
of poly(A+)
RNA insterol-treated CHO cells. Northern blot analysis of
poly(A+)RNA was performed as described under “Methods.” Hybridizations were performed using nick-translated cDNA probes to HMGCoA reductase (HMGR) and glutaraldehyde phosphate dehydrogenase (GAPDH).A representative autoradiogram is shown. C, ethanol
;
l5a-fluorolancontrol; 250H,25-hydroxycholestero1(2.3p ~ )15cu-F,
ost-7-en-3@-01(5p ~ ) .
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TABLE
I1
Effect of 25-hydroxycholestero1and 15a-fluorolnnost-7-en-3~-olupon HMG-CoA reductase activity and mRNA levels in treated CHO cells
CHO cells were treated with 25-hydroxycholestero1or the 15a-fluorolanosterol at 2.5 p~ for 16 h. Cells were harvested for HMG-CoA
reductase activity measurements and isolation of poly(A+) RNA. Activity and mRNA levels were determined as outlined under “Methods”
on pooled triplicate cultures. Quantitation of mRNA was done by cutting bands identified by autoradiography (see Fig. 5) and liquid
scintillation counting. HMGR, HMG-CoA reductase.
Condition

Exp. 1
Media
25-Hydroxycholesterol
15a-Fluorolanost-7-en-3~-ol

HMGR
activity“
prnol/rnin/mg

229+- 38
668
211+- 2
102
108 +- 8

HMGR
mRNA

TABLE
111
Effect of 25-hydroxycholesteroland 15a-fluorolanost-7-en-3fl-olupon
HMG-CoA reductase activity, mRNA, synthesis, and degradation in
treated CHO celk;
CHO cells were treated with 25-hydroxycholestero1 (25-OH)or
15a-fluorolanosterol(15a-F). Enzyme activity, mRNA levels, and
synthesis rates were determined as outlined under “Methods” and
values are expressed as a percent of control. Enzyme half-life was
determined as described in Fig. 6. All values are means f S.E., with
the number of independent experiments given in parentheses.

mRNA ratio
(HMGR/GAPDH)

189

1.16 (loo)*
0.69 (59)
2.44 (210)

dPm

266
145
462
(HMGR/Actin)

Exp. I1
Media
285
25-Hydroxycholestero1
387
15a-Fluorolanost-7-en-3/j”ol
Average of triplicate assays f S.D.
* Numbers in parentheses are percent media control value.

GAPDH
mRNA

856
376
1947

Actin
mRNA

mRNA ratio

375

2.28 (100)
1.32 (58)
5.03 (221)

rized in Table 111. These results suggest that 15a-fluorolanostenol, in contrast to 25-hydroxycholesterol, is a post-transcriptional regulator of HMG-CoA reductase which acts solely
at thelevel of translation.
DISCUSSION

The results presented in the currentstudy characterize the
metabolic behavior of 15a-fluorolanost-7-en-3~-01,
a synthetic
analogue of thenaturalsubstrate
for the lanosterol 14amethyl demethylase enzyme. We have shown that the 15aSterol
Activity
Protein
Synthesis
mRNA
Degradation’
tr(
fluorolanostenol functions as a substrate for the lanosterol
% control
h
14a-methyl demethylase, as well as serves as a good competControl
100
100100
100
3.1 t- 0.2 (9)
itive inhibitor of the enzyme. Our results substantiate and
25-OH 17 f 3 (4) 15 f 5 (3) 25 +- 5 (5) 20 f 4 (2) 1.3 +- 0.3 (3)
extend previous findings that 15-fluoro-substituted lanosten1 5 ~ ~ - F45 f 5 (7) 46 f 1 (2) 195 f 21 (4) 65 f 5 (4) 3.2 f 0.3 (5)
01s block cholesterol biosynthesis from lanosterol (30). By
virtue of the 15a-fluor0 substitution, it has been possible to
either pulse-labeled with [35S]methionine and chased with block complete metabolism of this lanosterol analogue to
excess unlabeled methionine in the presence or absence of demethylated sterolwhich results in accumulation of oxygensterol or pretreated for 16 h with 15a-fluorolanost-7-en-P-01 ated sterol undernormal metabolic conditions. These findings
and then labeled and chased in the presence of sterol. Al- indicate that 15a-fluor0 substitution in the lanostenol molethough pretreatment with sterol reduced the incorporation of cule is a modest modification which functions only to impede
[36S]methionineinto reductase during the 2-h pulse ( t = 0), metabolic conversion to end product cholesterol, but not other
the 150-fluorolanostenol had no effect on the half-life of the properties of the lanostenol molecule. Thus, the ability to
enzyme. The average rate of degradation of the newly synthe- generate a stableoxylanosterol analogue through metabolism
sized reductase determined in five separate experiments was of the 15a-fluorosterol asdescribed in this reportprovides us
not significantly different from that seen incontrol cells with another tool to study the mechanism of oxylanosterol
(Table 111). It has been suggested that sterol regulation of regulation of cholesterol synthesis and HMG-CoA reductase
reductase degradation is indirect and mediated by its effects activity.
on enzyme activity and mevalonate availability (7, 34). Thus
Experiments in culturedcells with the 15a-fluorolanostenol
the lack of effect of l5a-fluorolanostenol on HMG-CoA re- have demonstrated that the15a-fluorolanost-7-en-3P-01is an
ductase degradation might be related to its relative lack of active suppressor of HMG-CoA reductase activity under conpotency as an inhibitor or reductase (Table 11). To test this ditions when metabolism to an oxylanosterol analogue is
possibility, 25-hydroxycholesterol, apotenttranscriptional
permissive. We observe suppression of the HMG-CoA reducregulator of HMG-CoA reductase (Ref. 3 and Fig. 4), was taseactivity only in wild-type CHO cells andnot in the
added to cells at a concentration of 250 nM. This resulted in lanosterol 14a-methyl demethylase-deficient mutant, AR45.
a 45% decrease in HMG-CoA reductase activity after 6 h, a These results strongly suggest that metabolism of the 15avalue similar to thatseen when cells are treated for 16 h with fluorolanostenol by the lanosterol 14a-methyl demethylase
10 p M 15a-fluorolanostenol. Under these conditions, 25-hy- enzyme is required for suppressor activity. Additionally, the
droxycholesterol increased the rate of degradation of HMG- decrease in enzyme activity is accompanied by a decrease
CoA reductase 3.5-fold (data not shown). The inability
of 15a- immunoreactive protein which is consistent with previous
fluorolanostenol to accelerate reductase degradation is thus reports on oxylanosterol regulation of HMG-CoA reductase
not a result
of its more moderate inhibition of reductase activity (14).
activity. The data for oxysterol effects on HMG-CoA reducMechanistic studies with sterols, and in particular cholestase activity, mRNA, synthesis, and degradation are summa- terol and 25-hydroxycholesterol, have shown that sterol-de-
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the 5”flanking region of the reductase gene appears to be
responsible for sterol-dependent controlof gene transcription
and is thoughtto be the core binding site for a sterol-binding
protein which represses transcription (35-37). It has also been
demonstrated that regulation of reductase activity by sterols
correlates with the ability of sterols to interactwith a cytosolic
x
oxysterol-binding protein (38). Viewed collectively, these data
I
support the conclusion that sterols regulate HMG-CoA ren
n
ductase through transcriptional control mediated at least in
part through the action of a common oxysterol binding protein. The data we have presented, however, would indicate
I
that this general conclusion regarding sterols may not be
04
I
0
30
60
90
120
valid. Our results show that the 15a-fluorooxylanosterol analogue generated in situ regulates reductase expression
time(rnin)
through a post-transcriptional process. The decrease in reductase activity caused by the sterol is not accompanied by a
I
I
I
4000 i
decrease in reductase mRNA, but rather an actual increase.
Similar post-transcriptional control of HMG-CoA reductase
expression by 24,25-epoxylanosterol has been described (39).
When metabolism of this compound to the epoxycholesterol
was blocked, it no longer inhibited reductase activity in a rat
intestinal epithelial cell line. However, in both primary rat
hepatocytes and CHO cells, the oxidolanosterol post-transcriptionally inhibited reductase synthesis and enhanced reductase degradation even when its demethylation was inhibited with ketoconazole (39). In contrast to all other sterols
examined to date,treatment of CHO cells with the 15afluorolanostenol has no effect on the degradation rate of
0
6030
90
120
HMG-CoA reductase. The 15a-fluorooxylanostenol metabolite thus appears to be unique in the manner of its regulation
time (min)
of HMG-CoA reductase, inhibiting translation without affecting either transcription or enzyme degradation.
The present findings dictate that previous assumptions and
data used to support the concept of a non-steroidal regulator
of HMG-CoA reductase activity be re-evaluated. In particular,
the basic premise that all sterols regulate HMG-CoA reductase through a 25-hydroxycholestero1 mechanism is shown
here to be false. Thus, experiments which employ 25-hydroxycholesterol to totally account for sterol regulation are subject
to misinterpretation. For example, when 25-hydroxycholesterol is used in combination with mevalonic acid to regulate
HMG-CoA reductase activity, the mevalonic acid effect canlo2
not be assigned exclusively to a “non-steroidal” regulator. In
0
1
2
3
4
5
fact, conditions which employ mevalonic acid to generate a
non-steroidal regulator, either in mutant cells (6), or in comtime (hr)
bination experiments using 25-hydroxycholesterol plus comFIG. 6. Effects of 15a-fluorolanost-7-en-3~-ol
on HMGCoA reductase synthesis and degradation. A and B, CHO cells pactin (7), favor synthesis of oxylanosterols (15). Of interest
were labeledwith[3sS]methionine for the indicatedtimes in the inthis regard is the report that inhibition of HMG-CoA
presence of (0)or absence (0)of sterols.Incorporation of [%SI reductase by a 32-carboxylic acid derivative of lanosterol
methionine into total acid-perceptible
proteins and immunoprecipit- (SKF 104976) requires mevalonate (40), whereas inhibition
able HMG-CoA reductasewas determined as described under“Meth- by 24(S),25-oxidolanosteroldoes not (39).Additionally, Chin
ods.” A, acid-precipitable radioactivity. Data represent the average et al. (41) have shown that sterolscan effect HMG-CoA
and standard error of duplicate determinations on replicate dishes.
B , HMG-CoA reductase. Data represent disintegrations/min eluted reductase expression independently of transcriptional procfrom gel slices, corrected for nonspecific radioactivity. Curves were esses. Cohen and Griffioen (42) have also differentiated sterol
fitted by linear least squares analysis (Cricket Graph, Microsoft)(R2 metabolites of mevalonate whose effects upon reductase
> 0.9). C, CHO cells were pulse-labeled for 2 h with [35S]methionine mRNA can or cannot be replaced by exogenous low density
and chased in the presence of unlabeled methionine for the indicated lipoprotein. Thus, the designation of the reductase translatimes. Cells were harvested and radiolabeled HMG-CoA reductase
was quantitated as described under “Methods.” Curves were fitted bytional regulator as non-steroidalshould not be accepted withexponential least squares analysis (R2> 0.97). 0, ethanol control;0, out further proof of identity obtained through isolation and
15oc-fluorolanost-7-en-3~-01
was added at the beginning of the chase; absolute characterization.
W, cells were treated with 15a-fluorolanost-7-en-3~-ol
for 16 h prior
Our approach to understanding the mechanism of regulato the addition of label.
tion of HMG-CoA reductase by endogenously generated oxysterols has focused on the lanosterol 14a-methyl demethylapendent regulation of HMG-CoA reductase activity and tion cycle (13, 14, 16). Synthesis, chemical characterization,
expression is due to inhibition of transcription of the reduc- and metabolic studies with the novel substrate/inhibitor, 15atase gene (3). An octanucleotide cis-acting DNA sequence in fluorolanost”i-en-3~-ol,described in this report, extend our
I

I

I

1
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previous findings in this general area. The novel metabolic
behavior of the 15a-fluorolanostenol demonstrates the possibility that manipulation of the lanosterol demethylation cycle
through targeted synthesis can lead to a novel means to
control HMG-CoA reductase activity and cholesterol biosynthesis. Our activities are continuing in thisarea.
A ~ ~ n o ~ ~ ~ g ~ e thank
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e Kieras for technical assistance,
Dr. Gene Ness for supplying the anti-HMG-CoA reductase antibody,
and Dr. Leonard G. Davis for assistance on molecular biological
techniques.
REFERENCES
1. Rodwell, V. W., Nordstrom, J. L., and Mitschelen, J. J. (1976) Adu. Lipid
Res. 1 4 , l - 7 4
2. Brown, M. S., and Goldstein, J. L. (1980) J. Lipid Res. 21,505-517
3. Luskey, K. L., Faust, J. R., Chin, D. J., Brown, M. S., and Goldstein 3. L.
(1983) J. B i d . Chem. 258.8462-8469
4. Osborne, T. F., Goldstein, J. L., and Brown, N. S. (1985) Cell 42,203-212
5. Tanaka, R.D., Edwards, P. A,, Lan, S. F., and Fogelman, A. M. (1983) J.
Biol. Chem. 258,13331-13339
6. Peffley, D., and Sinensky, M. (1985) J. BioL Chem. 260,9949-9952
7. Nakanishi, M., Goldstein, J. L., and Brown, M. S. (1988) J . Biol. Chem.
263,8929-8937
8. Nelson, J. A., Steckbeck, S. R., and Spencer, T.A. (1981) J. Biol. Chem
256,1067-1068
9. Sexton, R. C., Panini, S. R., Agran, F., and Rudney, H. (1983) Biochemistry
22,5687-5692
10. Panini, S. R., Sexton, R. C, and Rudney, H.(1984) J. Bid. Chem. 259,
7767-7771
. . - . . . .11. Saucier, S. E., Kandutsch, A. A., Taylor, F. R., Spencer, T. A., Phinwa, S.,
and Gayen, A. K. (1985) J . Biol. Chem. 260,14571-14579
12. Gibbons, G. F., Pullinger, C. R., Chen, H. W. Cavenee, W. K., and Kandutsch, A. A. (1980) J . Biol. Chem. 255,395-400
13. Favata, M. F., Trzaskos, J. M., Chen, H. W., Fischer, R. T., and Greenberg,
R. S. (1987) J. Biol. Chem. 262,12254-12260
14. Trzaskos, J. M., Favata, M. F., Fischer, R. T., and Stam, S. H. (1987) J.
Biol. Chem. 262,12261-12269
15. Saucier, S. E., Kandutsch, A. A., Phinwa, S., and Spencer, T. A. (1987) J.
Biol. Chem. 262,14056-14062
16. Trzaskos, J. M., Fischer, R. T., and Favata, M.F. (1986) J. Biol. Chem.
2 6 1 , 16937-16942

22599

17. Gibbons, G. F., Bjornsson, 0. G., and Pullinger, C. R., (1984) J. Bi01. Chem.
259,14399-14405
18. Chen, H. W..Leonard, D. A., Fischer, R. T., and Trzaskos, J. M. (1988) J.
Bwl. Chem. 263,1248-1254
19. Gibbons. G . F.. Goad. , L. J... and Goodwin. T. W. (1968) Chen. Commun.
22,1458-1460
20. Trzaskos, J. M., and Gaylor, J. L. (1985) in The Enzymes of Biological
Membranes (Martonosi, A. N., ed) Vol. 2, pp. 177-204, Plenum Press,
NPW
.
. .. Ynrk
- ....
21. Shaflee, A., Trzaskos, J. M., Paik, Y.-K., and Gaylor, J. L. (1986) J. Lipid
Res. 2 7 , l - 1 0
22. Leonard, D. A,, and Chen, H. W.(1987) J. Biol. Chem. 262,7914-7919
23. Davis, L. G., Dibner, M.D., and Battey, J. E. (1986) Busic Methods in
Molecular Biology, Elsevier Science Publishing Co., Inc., New York
24. Katcoff, P. Nude1 V. Zevin-Sonkin D., Carmon, Y., Shani, M., Lehrach,
H., Frischauf, M., and Yaffe, D: (1980) Proc. Natl. Acad. Sci. U. S . A .
25. Manning, R. W., Reid, C. M., Lampe, R. A,, and Davis, L. G. (1988) Mol.
Bmin Res. 3 , 293-298
26. Woodward, R.B., Patchett, A. A., Barton, D. H. R., Ives, D. A. J., and
Kelly, R. B. (1957) J. Chem. SOC.1131-1144
27. Bloch, K., and Gautschi, F. (1958) J. Biof. Chem. 233,1343-1347
28. Phillips, G. N., Quiocho, F. A,, Sass, R. L., Werness, P., Emery, H.,Knapp,
F. F., and Schroe fer, G. J. (1976) Bioorg. C k m . 5,1-10
29. Gibbons, G. F., andkamanada, K. (1975) J. Chem. Soc. Chem. Commun.
213-214
30. Morisaki, M., Sonoda, Y., Makino, T., Oyihara, N., Ikekawa, N., and Sato,
Y. (1987) J. Biochem. (Tokyo)99,597-600
31. Gunther, H.(1980) NMR Spectroscopy, First Ed., pp. 351-352, J. Wiley

A.

and
New
-.
.- Song.
- ..", .
. . York
..
.
.

32. Fischer, R. T., Stam, S. H., Johnson, P. R.,KO, S. S., Magolda,R. L.,
Gaylor, J. L., and Trzaskos, J. M. (1989) J. Li id Res. 20,1621-1632
33. Fischer, R. T., Trzaskos, J. M., Magolda, R. L., Eo, S. S., Brosz, C. S., and
Larsen, B. (1991) J. Biol Chem. 266,6124-6132
34. Orci, L., Brown, M. S., Goldstein, J. L., Garcia-Segura, L. M., and Anderson,
R. G. (1984) Cell 36,835-845
35. Osborne, T. F., Gil, G., Goldstein, d . L., and Brown, M. S. (1988) J. Biol.
Chem. 263,3380-3387
36. Oshorne, T. F. (1991) J. Biol. Chem. 266,13947-13951
37. Osborne, T. F., Bennett, M., and Rhee, K. (1992) J. Biol. Chem. 2 6 7 ,
18973-18982
~
. .
38. Taylor, F. R., Saucier, S. E., Shown, E. P., Parish, E. J., and Kandutsch,
A. A. (1984) J. Biol. Chem. 259,12382-12387
39. Panini, S. R., Delate, T. A., and Sinensky, M. (1992) J. Biol. Chem. 2 6 7 ,
12647-12654
40. Mayer, R. J., Adams, J. L., Bossard, M. J., and Berkhout, T. A. (1991) J.
Bid. Chem. 266,20070-20078
41. Chin, D. J., Gil, G., Faust, JI R., Goldstein, J. L., Brown, M. S., and Luskey,
K. L. (1985) Mol. Cell. Bzol. 5 , 634-641
42. Cohen, L. H., and Griffioen, M. (1988) Bioehem. J. 255,61-67
~

